계명대학교 의학도서관 Repository

Safety and efficacy of a novel hyperaemic agent, intracoronary nicorandil, for invasive physiological assessments in the cardiac catheterization laboratory

Metadata Downloads
Affiliated Author(s)
남창욱
Alternative Author(s)
Nam, Chang Wook
Journal Title
European Heart Journal
ISSN
0195-668X
Issued Date
2013
Abstract
Aims Maximal hyperaemia is a key element of invasive physiological studies and adenosine is the most commonly used
agent. However, infusion of adenosine requires additional venous access and can cause chest discomfort, bronchial
hyper-reactivity, and atrioventricular conduction block. The aim of this study was to evaluate the feasibility and efficacy
of intracoronary (IC) nicorandil as a novel hyperaemic agent for invasive physiological studies.
Methods
and results
We enrolled 210 patients who underwent fractional flow reserve (FFR) measurement. Hyperaemic efficacy of the
following methods was compared: IC bolus injection of adenosine; intravenous (i.v.) infusion of adenosine
(140 mg/kg/min); and IC bolus of nicorandil (1 and 2 mg). In 70 patients, the index of microcirculatory resistance
was also measured. Hyperaemic efficacy of IC nicorandil 2 mg was non-inferior to that of i.v. adenosine infusion
(FFR: 0.82+0.10 vs. 0.82+0.10; P for non-inferiority , 0.001). There was a strong correlation between FFRs measured
by i.v. adenosine and IC nicorandil (R2 ¼ 0.934). Nicorandil produced fewer changes in blood pressure, heart
rate and PR interval, and less chest pain than adenosine (all P-values , 0.05). Atrioventricular block occurred in 12
patients with IC adenosine, 4 patients with i.v. adenosine and none with IC nicorandil. The index of microcirculatory
resistance was 18.3+8.7 with i.v. adenosine and 17.2+7.6 with IC nicorandil (P ¼ 0.126).
Conclusion This study suggests that IC bolus injection of nicorandil is a simple, safe, and effective way to induce steady-state
hyperaemia for invasive physiological evaluations.
Clinicaltrials.gov number: NCT01331902.
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Keywords Fractional flow reserve † Hyperaemia † Nicorandil
Department
Dept. of Internal Medicine (내과학)
Publisher
School of Medicine
Citation
Ho-Jun Jang et al. (2013). Safety and efficacy of a novel hyperaemic agent,
intracoronary nicorandil, for invasive
physiological assessments in the cardiac
catheterization laboratory. European Heart Journal, 34(27), 2055–2062. doi: 10.1093/eurheartj/eht040
Type
Article
ISSN
0195-668X
DOI
10.1093/eurheartj/eht040
URI
https://kumel.medlib.dsmc.or.kr/handle/2015.oak/35649
Appears in Collections:
1. School of Medicine (의과대학) > Dept. of Internal Medicine (내과학)
공개 및 라이선스
  • 공개 구분공개
  • 엠바고Forever
파일 목록

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.